Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Amphotericin B
13%
Anidulafungin
8%
Antibiotics
5%
Antifungal Agent
20%
Antifungal Therapy
9%
Antiinfective Agent
7%
Aspergillosis
5%
Aspergillus fumigatus
9%
Bioavailability
6%
Caspofungin
9%
Ciprofloxacin
9%
Clinical Trial
5%
Diseases
15%
Drug-Drug Interaction
6%
Echinocandin
5%
Flucloxacillin
8%
Fluconazole
14%
Gentamicin
5%
Infection
17%
Invasive Aspergillosis
19%
Isavuconazole
13%
Itraconazole
7%
Malignant Neoplasm
5%
Micafungin
12%
Minimum Inhibitory Concentration
5%
Mycosis
8%
Normal Human
11%
Pharmacodynamics
19%
Pharmacokinetic Modeling
5%
Pharmacokinetics
100%
Posaconazole
30%
Prevalence
5%
Pyrrole
17%
Pyrrole Derivative
5%
Systemic Mycosis
7%
Tacrolimus
6%
Therapeutic Drug Monitoring
23%
Triazole
5%
Vancomycin
6%
Volume of Distribution
5%
Voriconazole
25%
Keyphrases
Anidulafungin
6%
Antifungal Therapy
9%
Azoles
8%
Caspofungin
6%
COVID-19
7%
Critically Ill Patients
12%
Dried Blood Spots
5%
Flucloxacillin
5%
Intensive Care Unit Patients
5%
Invasive Aspergillosis
7%
Invasive Fungal Disease
8%
Invasive Fungal Infection
5%
Isavuconazole
9%
Lamb
7%
Micafungin
5%
Morbid Obesity
6%
Obesity
5%
Pediatric Patients
5%
Pharmacokinetic Study
8%
Pharmacokinetic/pharmacodynamic (PK/PD)
5%
Pharmacokinetics
28%
Plasma Concentration
5%
Population Pharmacokinetics (PopPK)
6%
Posaconazole
15%
Pulmonary Aspergillosis
5%
Target Attainment
8%
Therapeutic Drug Monitoring
12%
Voriconazole
13%
Medicine and Dentistry
Aspergillus
5%
COVID-19
12%
Diseases
5%
Invasive Aspergillosis
11%
Lung Aspergillosis
8%
Mycosis
5%
Therapeutic Drug Monitoring
5%
